Secondary hematological malignancies after treatment of non-metastatic breast cancer

Journal of B.U.ON.

Volumn 16, Issue 4, 2011, Pages 744-750

  Arslan, Cagatay ^a   Ozdemir, E ^a   Dogan, E ^a   Ozisik, Y ^a   Altundag, K ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Chemotherapy; Hematological malignancies; Non metastatic; Radiotherapy; Secondary

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; NAVELBINE; PACLITAXEL;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE MYELOMA; RETROSPECTIVE STUDY;

AGED; BREAST NEOPLASMS; CHEMORADIOTHERAPY, ADJUVANT; CHEMOTHERAPY, ADJUVANT; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; TURKEY;

EID: 84855437582     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Fisher B, Rockette H, Fisher ER, Wickerham DL, Redmond C, Brown A. Leukemia in breast cancer patients following adjuvant chemomerapy or postoperative radiation: the NSABP experience. J Clin Oncol 1985; 3: 1640-1658. (Pubitemid 16199216)
2. Park MJ, Park YH, Ahn HJ et al. Secondary hematological malignancies after breast cancer chemotherapy. Leuk Lymphoma 2005; 46: 1183-1188. (Pubitemid 41087024)
3. Hershman D, Neugut AI, Jacobson JS et al. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst 2007; 99: 196-205.
4. Le Deley MC, Suzan F, Cutuli B et al. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer. J Clin Oncol 2007; 25: 292-300. (Pubitemid 350003017)
5. Singhal M, Raina V, Gupta R, Das P. T cell-prolymphocytic leukemia detected in a patient of breast cancer at the time of recurrence: a case report. Cases J 2010; 3: 4-8.
6. Curtis RE, Boice JD Jr, Moloney WC, Ries LG, Flannery JT. Leukemia following chemomerapy for breast cancer. Cancer Res 1990; 50: 2741-2746. (Pubitemid 20150215)
7. Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100: 1989-1996. (Pubitemid 35001228)
8. Riedel DA, Pottern LM. The epidemiology of multiple myeloma. Hematol Oncol Clin North Am 1992; 6: 225-247.
9. Haase D, Binder C, Bünger J et al. Increased risk for therapy--associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res 2002; 26: 249-254. (Pubitemid 34037021)
10. Weldon CB, Jaffe BM, Kahn MJ. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol 2002; 9: 738-744.
11. Curtis RE, Boice JD Jr, Stovall M et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N Engl JMed 1992; 326: 1745-1751.
12. Smith RE, Bryant J, DeCillis A, Anderson S; National Surgical Adjuvant Breast and Bowel Project Experience. Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer the National Surgical Adjuvant Breast and Bowel Project Experience. J Clin Oncol 2003; 21: 1195-1204. (Pubitemid 46894010)
13. Chaplain G, Milan C, Sgro C, Carli PM, Bonithon-Ropp C. Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: a population-based study. J Clin Oncol 2000; 18: 2836-2842. (Pubitemid 30620071)
14. Pedersen-Bjergaard J, Sigsgaard TC, Nielsen D et al. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epidoxorubicin and cisplatin or cyclophosphamide for breast cancer. J Clin Oncol 1992; 10: 1444-1451. (Pubitemid 23059928)
15. Saso R, Rulkarni S, Mitchell P et al. Secondary myelodys-plastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma. Br J Cancer 2000; 83: 91-94. (Pubitemid 30352723)
16. Seiter K, Feldman EJ, Sreekantaiah C et al. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy. Leukemia 2001; 15: 963-970. (Pubitemid 32529898)
17. Beadle G, Baade P, Fritschi L. Acute myeloid leukemia after breast cancer: a population-based comparison with hematological malignancies and other cancers. Ann Oncol 2009; 20: 103-109.
18. Part DA, Duan Z, Fang S, Hortobagyi GN, Giordano SH. Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk. J Clin Oncol 2007; 25: 3871-3876. (Pubitemid 47477263)
19. Tallman MS, Gray R, Bennett JM et al. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer the Eastern Cooperative Oncology Group experience. J Clin Oncol 1995; 13: 1557-1563.
20. Praga C, Bergh J, Bliss J et al. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer correlation with doses of epirubicin and cyclophosphamide. J Clin Oncol 2005; 23: 4179-4191. (Pubitemid 46211324)
21. Kröger N, Zander AR, Martinelli G et al. Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation. Ann Oncol 2003; 14: 554-548.
22. Andersson M, Storm HH, Mouridsen HT. Carcinogenic effects of adjuvant tamoxifen treatment and radiotherapy for early breast cancer. Acta Oncol 1992; 31: 259-263.
23. Valagussa P, Moliterni A, Terenziani M, Zambetti M, Bonadonna G. Second malignancies following CMF-based ad-juvant chemotherapy in resectable breast cancer. Ann Oncol 1994; 5: 803-808. (Pubitemid 24341872)
24. Diamandidou E, Buzdar AU, Smith TL, Frye D, Witjaksono M, Hortobagyi GN. Treatment-related leukemia m breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 1996; 14: 2722-2730. (Pubitemid 26329658)
25. Laughlin MJ, McGaughey DS, Crews JR et al. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol 1998; 16: 1008-1012. (Pubitemid 28108734)
26. Linassier C, Barin C, Calais G et al. Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy. Ann Oncol 2000; 11: 1289-1294.